Gaviria-García JR, Ospina-Sánchez JP, Martínez-Sánchez LM, Jaramillo-Jaramillo LI, Urrego-Vásquez A, Hernández-Restrepo F

Language: Spanish
References: 31
Page: 1-12
PDF size: 355.31 Kb.

ABSTRACT

Introduction: In orthopedics, one of the worst complications after a surgical procedure is venous thrombosis, being the main cause of morbidity and mortality and hospital readmission after a hip or knee arthroplasty.
Objective: To synthesize and describe information on the use of thromboprophylaxis and the risk of thromboembolic complications in orthopedic surgery.
Methods: A review of the literature was carried out in the databases Scielo, ScienceDirect, PubMed and Lilacs with the descriptors: thrombosis, orthopedics, prevention & control, in Spanish and English. We included 32 articles with a review focused on thromboprophylaxis in orthopedic surgery and adherence compliance.
Results: The risk that a patient presents or develops perioperative thromboembolic complications is about 10 to 50 % according to the literature, which depends on the type of surgery and the individual risk factors. In the case of orthopedic surgeries, the use of this treatment avoids complications, reinterventions and a long hospital stay.
Conclusions: A good adherence to the thromboprophylactic protocols is important, including the choice of the correct medication, the appropriate dose, the time required and the necessary controls to avoid any thrombotic event.

REFERENCES

1. Pérez-García A, Briones-Pérez B. Tromboprofilaxis en pacientes postquirúrgicos: revisión de 1,500 casos. Cir Ciruj. 2004;72:287-91.

2. Baker D, Sherrod B, McGwin G, Ponce B, Gilbert S. Complications and 30-day Outcomes Associated with Venous Thromboembolism in the Pediatric Orthopaedic Surgical Population. J Am Acad Orthop Surg. 2016;24(3):196-206.

3. Dixon J, Ahn E, Zhou L, Lim R, Simpson D, Merriman EG. Venous thromboembolism rates in patients undergoing major hip and knee joint surgery at Waitemata District Health Board: a retrospective audit. Intern Med J. 2015; 45(4):416-22.

4. Chandrakumar A, Muhamed AM, Suriyaprakash TNK, Ajmal KK. Prevalence of venous thromboembolism risk factors and prophylactic adequacy among general surgical patients in a tertiary care hospital. Indian Heart J. 2016;68:513-8.

5. Granero J, Soler JM, García L. Enfermedad tromboembólica en pacientes de cirugía ortopédica. Med Clin (Barc). 2008;131(Supl 2):18-24. 6. Bautista M, Llinás A, Bonilla G, Mieth K, Diaz M, Rodriguez F; Clinical Care Program in Joint Replacements. Thromboprophylaxis after major orthopedic surgery: Improving compliance with clinical practice guidelines. Thromb Res. 2016;137:113-8.

6. Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e278S-e325S.

7. Chan NC, Siegal D, Lauw MN, Ginsberg JS, Eikelboom JW, Guyatt GH, et al. Asystematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisal. J Thromb Thrombolysis. 2015;40(2):231-9.

8. Gómez LF. Medicamentos anticoagulantes y antitrombóticos. En: Gómez LF, editor. Medicina vascular. 1º ed. Medellín: CIB; 2016. p. 271-77.

9. Oprea AD, Noto CJ, Halaszynski TM. Risk stratification, preoperative and periprocedural management of the patient receiving anticoagulant therapy. JCA. 2016;34:586-99.

10. Greinacher A. Heparin-induced thrombocytopenia. N Engl J Med. 2015;373:252-61.

11. Egan G, Ensom MH. Measuring anti-factor Xa activity to monitor low-molecular-weight heparin in obesity: a critical review. Can J Hosp Pharm. 2015;68:33-47.

12. Dzik WS. Reversal of drug-induced anticoagulation: old solutions and new problems. Transfusion. 2012;52(1):45S-55S.

13. Ortiz-Ruíz G, Ariza-Cadena F, Trujillo A, Bejarano A, Gutiérrez JM, Gálves K, et al. Manejo del sangrado y la coagulación en la práctica clínica. Evaluación de la evidencia y recomendaciones mediante estrategia GRADE. Primera reunión de expertos. Acta Colomb Cuid Intensivo. 2016;16(3):123-242.

14. Moreno Carrillo A, Pulido Arenas J, Bejarano Zuleta JA. Concentrados de complejo protrombínico en el servicio de urgencias. Rev Med Interna Mex. 2014;30:56-65.

15. Crowther M, Crowther MA. Antidotes for novel oral anticoagulants: cur- rent status and future potential. Arterioscler Thromb Vasc Biol. 2015;35:1736-45.

16. Daniels PR. Peri-procedural management of patients taking oral anticoagulants. BMJ. 2015;351:h2391.

17. Levy JH, Faraoni D, Spring JL, Douketis JD, Samama CM. Managing new oral anticoagulants in the perioperative and intensive care unit set- ting. Anesthesiology. 2013;118:1466-74.

18. Douketis J, Bell AD, Eikelboom J, Liew A. Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions. Can Fam Physician. 2014;60:997-1001.

19. Haas S, Holberg G, Kreutz R, Lassen MR, Mantovani L, Haupt V, et al. The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study. Vasc Health Risk Manag. 2016;12:209-18.

20. Mandernach MW, Beyth RJ, Rajasekhar A. Apixaban for the prophylax- is and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review. Ther Clin Risk Manag. 2015;11:1273-82.

21. Plante S, Belzile EL, Fréchette D, Lefebvre J. Analysis of contributing factors influencing thromboembolic events after total knee arthroplasty. Can J Surg. 2017;60(1):30-6.

22. Conthe P, Márquez E, Aliaga A, Barragán B, Fernández de Cano MN, González Jurado M, et al. Treatment compliance in chronic illness: Current situation and future perspectives. Rev Clin Esp. 2014;214(6):336-44.

23. Selby R, Borah B, McDonald H, Henk H, Crowther M, Wells P. Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement. Thrombosis Research. 2012;130(2):166-72.

24. Farfan M, Bautista M, Bonilla G, Rojas J, Llinás A, Navas J. Worldwide adherence to ACCP guidelines for thromboprophylaxis after major orthopedic surgery: A systematic review of the literature and meta-analysis. Thrombosis Research. 2016;141:163-70.

25. Dennis R, Roa J, Villadiego J, Méndez F, Vieda E, Restrepo H. Profilaxis de la tromboembolia venosa en pacientes colombianos de tratamiento médico o quirúrgico: resultados para Colombia del estudio ENDORSE. Biomédica. 2011;31(2):200.

26. Arcelus J, Felicissimo P. Venous thromboprophylaxis duration and adherence to international guidelines in patients undergoing major orthopaedic surgery: Results of the international, longitudinal, observational DEIMOS registry. Thrombosis Research. 2013;131(6):e240-e246.

27. Kakkar A, Cohen A, Tapson V, Bergmann J, Goldhaber S, Deslandes B, et al. Venous Thromboembolism Risk and Prophylaxis in the Acute Care Hospital Setting (ENDORSE Survey). Annals of Surgery. 2010;251(2):330-38.

28. Randelli F, Cimminiello C, Capozzi M, Bosco M, Cerulli G. Real life thromboprophylaxis in orthopedic surgery in Italy. Results of the GIOTTO study. Thromb Res. 2016;137:103-07.

29. Merli G, Malangone E, Lin J, Lamerato L, Stern L. Real-world practices to prevent venous thromboembolism with pharmacological prophylaxis in US orthopedic surgery patients: an analysis of an integrated healthcare database. Journal of Thrombosis and Thrombolysis. 2011;32(1):89-95.

30. Gao Y, Long A, Xie Z, Meng Y, Tan J, Lv H, et al. The compliance of thromboprophylaxis affects the risk of venous thromboembolism in patients undergoing hip fracture surgery. Springer Plus. 2016;5(1):1236.

31. Peidro-Garcés L, Otero-Fernandez R, Lozano-Lizarraga L. Adherencia y satisfacción en la profilaxis antitrombótica ambulatoria oral frente a la parenteral: estudio SALTO. Revista Española de Cirugía Ortopédica y Traumatología. 2013;57(1):53-60.